Business Update
Vasovist maker to reduce workforce
Published in Medical Letter on the CDC and FDA, January 15th, 2006
The reductions will affect both the research and development and the general and administrative areas of the company.
Prior to the initial announcement on November 23, 2005 of the company's intention to reduce its workforce, the company had 93 employees. Following the completion of the reduction, the company expects that it will have approximately 48 employees.
EPIX received the second approvable letter from...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Amebiasis Diagnosis
Report compares real-time PCR protocols for differential diagnosis of amebiasis - Hemophilia Epidemiology
Report reviews demographics of hemophilia in developing countries - Streptococcus Epidemiology
Clonal association found between Streptococcus pneumoniae serotypes 23A and 23F - Vaccine Efficacy
Hepatitis A immunization program aimed at child-care centers proves successful - Acute Lymphoblastic Leukemia
European study confirms efficacy of clofarabine in pediatric patients with ALL - Acute Peripheral Arterial Occlusion
U.S. FDA specifies protocol for phase III trial of novel arterial perfusion with alfimeprase-3 - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
